Vancouver, BC – November 17, 2020 – Maitri Health Technologies Corp. (formerly, Dizun International Enterprises Inc.) (CSE: MTEC, formerly CSE: KDZ.X) (“Maitri” or the “Company”) is pleased to announce that further to its news releases dated August 10, 2020, September 10, 2020 and November 13, 2020, the Company has completed the previously announced amalgamation transaction (the “Transaction”) with Maitri Holdings Corp. (formerly, Maitri Health Corp.) and has received final approval to list the Resulting Issuer Shares (as defined below) on the Canadian Securities Exchange (“CSE”) pursuant to the amended and restated amalgamation agreement dated October 7, 2020 (the “Amalgamation Agreement”) among the Company, Maitri Health Corp. and 1264381 B.C. Ltd.
Maitri will list 12,750,000 common shares (the “Resulting Issuer Shares”) on the CSE and the Resulting Issuer
Shares are expected to begin trading on November 19, 2020 (the “Trading Resumption Date”) under the symbol “MTEC”.
In addition, in connection with the closing of the Transaction, Maitri issued an aggregate of 500,000 Resulting
Issuer Shares to certain finders as a finder’s fee for introducing the parties to the Transaction.
Trading in the common shares of the Company has been halted by the CSE since September 10, 2020 following the announcement of the Amalgamation Agreement and is expected to remain halted until the Trading Resumption Date.
For more information, please contact the Company at:
Maitri Health Corp.
Cautionary Note on Forward Looking Information
This news release contains forward‐looking statements and forward‐looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward‐looking statements or information. More particularly and without limitation, this news release contains forward‐looking statements and information relating to the listing of the Resulting Issuer Shares, and other matters. The forward‐looking statements and information are based on certain key expectations and assumptions made by management of the Company. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward‐looking statements and information since no assurance can be given that they will prove to be correct.
Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward‐looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to raise further capital and the Company’s ability to obtain regulatory and exchange approvals. Accordingly, readers should not place undue reliance on the forward‐looking statements
and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.
The forward‐looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward‐looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.
Neither the Canadian Securities Exchange nor the Investment Industry Regulatory Organization of Canada accepts responsibility for the adequacy or accuracy of this release.